RABLERA
DEAD

Serial Number

79195018

Owner

NOVARTIS AG

Filing Date

Sep 19, 2016

Add to watchlist:

No watchlists yet
View on USPTO

RABLERA Trademark

Serial Number: 79195018 • Registration: 5153382

RABLERA is a trademark filed by NOVARTIS AG on September 19, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

September 19, 2016

Registration Date

March 7, 2017

Published for Opposition

December 20, 2016

Cancellation Date

November 5, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

DEATH OF INTERNATIONAL REGISTRATION
Jun 2, 2025 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Jul 20, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 28, 2024 INTS
INVALIDATION PROCESSED
Jun 27, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 14, 2024 INTR
CANCELLED SECTION 71
Sep 22, 2023 C71T
NOTIFICATION PROCESSED BY IB
Apr 21, 2017 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Apr 6, 2017 FICS
FINAL DISPOSITION PROCESSED
Apr 6, 2017 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Apr 6, 2017 GPAR
REGISTERED-PRINCIPAL REGISTER
Mar 7, 2017 R.PR
PUBLISHED FOR OPPOSITION
Dec 20, 2016 PUBO
NOTICE OF PUBLICATION
Nov 30, 2016 NPUB
APPLICATION FILING RECEIPT MAILED
Nov 8, 2016 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 4, 2016 CNSA
ASSIGNED TO EXAMINER
Nov 4, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 2, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 28, 2016 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Oct 27, 2016 SDRC